[1] Cross M, Smith E, Hoy D, et al. The global burden of rheumatoid arthritis: estimates from the global burden of disease 2010 study[J]. Ann Rheum Dis, 2014,73(7):1316-1322. [2] Tanaka D, Kagari T, Doi H, et al. Essential role of neutrophils in anti-type II collagen antibody and lipopolysaccharide-induced arthritis[J]. Immunology, 2006,119(2):195-202. [3] Wright HL, Moots RJ, Bucknall RC, et al. Neutrophil function in inflammation and inflammatory diseases[J]. Rheumatology (Oxford), 2010,49(9):1618-1631. [4] Kaplan MJ. Neutrophils in the pathogenesis and manifestations of SLE[J]. Nat Rev Rheumatol, 2011,7(12):691-699. [5] Wright HL, Moots RJ, Edwards SW. The multifactorial role of neutrophils in rheumatoid arthritis[J]. Nat Rev Rheumatol, 2014,10(10):593-601. [6] Delgado-Rizo V, Martínez-Guzmán MA, Iñiguez-Gutierrez L, et al. Neutrophil extracellular traps and its implications in inflammation: an overview[J]. Front Immunol, 2017,8:81. [7] Khandpur R, Carmona-Rivera C, Vivekanandan-Giri A, et al. NETs are a source of citrullinated autoantigens and stimulate inflammatory responses in rheumatoid arthritis[J]. Sci Transl Med, 2013,5(178):178ra40. [8] Spengler J, Lugonja B, Ytterberg AJ, et al. Release of active peptidyl arginine deiminases by neutrophils can explain production of extracellular citrullinated autoantigens in rheumatoid arthritis synovial fluid[J]. Arthritis Rheumatol, 2015,67(12):3135-3145. [9] Lin C, Shao Y, Zeng C, et al. Blocking PI3K/AKT signaling inhibits bone sclerosis in subchondral bone and attenuates post-traumatic osteoarthritis[J]. J Cell Physiol, 2018,233(8):6135-6147. [10] Pérez-Sánchez C, Ruiz-Limón P, Aguirre MA, et al. Diagnostic potential of NETosis-derived products for disease activity, atherosclerosis and therapeutic effectiveness in Rheumatoid Arthritis patients[J]. J Autoimmun, 2017,82:31-40. [11] Chen W, Wang Q, Ke Y, et al. Neutrophil function in an inflammatory milieu of rheumatoid arthritis[J]. J Immunol Res, 2018,2018:8549329. [12] Weissmann G, Korchak H. Rheumatoid arthritis. The role of neutrophil activation[J]. Inflammation, 1984,8 Suppl: S3-14. [13] Saku A, Fujisawa T, Nishimoto K, et al. Prognostic significance of peripheral blood monocyte and neutrophil counts in rheumatoid arthritis-associated interstitial lung disease[J]. Respir Med, 2021,182:106420. [14] Wang S, Lai X, Li C, et al. Sialic acid-conjugate modified doxorubicin nanoplatform for treating neutrophil-related inflammation[J]. J Control Release, 2021,337:612-627. [15] Németh T, Sperandio M, Mócsai A. Neutrophils as emerging therapeutic targets[J]. Nat Rev Drug Discov, 2020,19(4):253-275. [16] Bach M, Moon J, Moore R, et al. A neutrophil activation biomarker panel in prognosis and monitoring of patients with rheumatoid arthritis[J]. Arthritis Rheumatol, 2020,72(1):47-56. [17] Rada B. Neutrophil extracellular traps and microcrystals[J]. J Immunol Res, 2017,2017:2896380. [18] Yin K, Cui Y, Qu Y, et al. Hydrogen sulfide upregulates miR-16-5p targeting PiK3R1 and RAF1 to inhibit neutrophil extracellular trap formation in chickens[J]. Ecotoxicol Environ Saf, 2020,194:110412. [19] 谢小倩,王亚乐,罗沙沙,等.类风湿性关节炎发病机制研究进展[J].世界最新医学信息文摘,2019,19(71):109-111. |